Gf Fund Management Co. Ltd. Autolus Therapeutics PLC Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,193 shares of AUTL stock, worth $8,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,193Holding current value
$8,176% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
112Shares Held
156MCall Options Held
0Put Options Held
116K-
Wellington Management Group LLP Boston, MA25.3MShares$49.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$39.9 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$32.4 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$27.7 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$19.3 Million0.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $177M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...